Get 250+ investors tailored to your startup

Invest in your industry and stage
Emails & contact info included
Excel and CSV export
Automatically

Trusted by 3,000+ startups

Top 25 Biotechnology Angel Investors in LATAM in November 2024

Last updated: Nov 2024 A list of 25 angel investors that invest in Biotechnology startups based in Latam. We rank investors based on the number of investments they made in Biotechnology companies from Latam. We update this investor list every month.

Top 25 Biotechnology Angel Investors in LATAM in November 2024

Investor	Biotechnology LATAM investments
Kevin Efrusy	2
Daniel Gold	1
Pablo Pla	1
Steve Zurcher	1
Elizabeth Iorns	1
Robert Stavis	1
Thomas James	1
Sohail Prasad	1
Jessica Livingston	1
Jason Burke	1
Fabricio Bloisi	1
Bob Goodman	1
Geoffrey KALISH	1
Dan Knox	1
Eric Urhane	1
Mat Travizano	1
Paul Buchheit	1
Jeff Horing	1
Martin Torres Cava	1
Ashton Kutcher	1
Armínio Fraga	1
Matt Cutts	1
Jun Ueki	1
Wolfgang Schuch	1
Eduardo Mufarej	1

Find investors that fund startups like yours. Automatically.

Our algorithm will find investors that invest in your industry, stage, and geography.

Investor list

Kevin Efrusy is the Co-Founder of The Efrusy Family Foundation and a Partner at Accel. Prior to that, he was the CEO and board member, and co-founder of IronPlanet. He attended Stanford University Graduate School of Business and Stanford University.

Investment focus

E-Commerce, Software, Financial Services
Series B, Series A, Series C
Brazil, United States, Mexico

Portfolio highlights

Sami — Sami is a Brazil-based health plan startup that provides a technology-based solution intended to be used in the healthcare sector. The company focuses on making health care simpler, more efficient, and friendlier by using simplified solutions, thus, providing patients with reduced costs for their medical care needs. Their mission is to transformBrazilian health into something simple, easy, reliable, and accessible, which helps each person to be their best version.Founded by Vitor Asseituno and Luiz Guilherme Berardo in 2018 and is based in São Paulo, Brazil.
Zubale — Zubale is the critical infrastructure that enables retailers to win in e-commerce. Through our gig workers marketplace and technical integrations we power our clients entire back end e-commerce operations delivering the best fill-rates, on-times and NPS. In the last year, Zubale has completed over 3 million jobs across 90 cities and 16,800 stores.We operate in Mexico, Colombia and Costa Rica and are scaling across Latin America. The Co-Founders Allison Campbell and Sebastian Monroy met during their Harvard MBA and are retail insiders with deep expertise at Walmart and P&G in Latin America, Africa, India and China.
PhageLab — Record time development of tailor-made solutions to control bacterial outbreaks in the livestock and poultry industries.

Daniel Gold

Investment focus

Genetics, Life Science, Biotechnology
Pre-Seed
Brazil

Portfolio highlights

gen-t — Gen-t is a platform capable of providing the map of genomic research. Gen-t was founded in 2021 and was headquartered in Sao Paulo, Brazil.

Pablo Pla is the Chief Executive Officer of San Miguel. He Previously worked at Ingredion Incorporated as a President and General Manager. Pablo Pla attended Columbia Business School.

Investment focus

Biopharma, Biotechnology, Food Processing
Seed
Argentina

Portfolio highlights

Michroma — Michroma is a biotech platform producing natural ingredients in a sustainable, scalable, and cost-effective way. We are using synthetic biology to unleash the potential of filamentous fungi and develop proprietary strains capable of producing high-performance ingredients in bioreactors.

Steve Zurcher

Investment focus

Biopharma, Biotechnology, Food Processing
Seed
Argentina

Portfolio highlights

Michroma — Michroma is a biotech platform producing natural ingredients in a sustainable, scalable, and cost-effective way. We are using synthetic biology to unleash the potential of filamentous fungi and develop proprietary strains capable of producing high-performance ingredients in bioreactors.

Elizabeth Iorns is the Co-Founder, President, and CEO of Science Exchange. She previously worked at Y Combinator as a Part-time partner. Elizabeth Iorns attended the University of Auckland.

Investment focus

Software, SaaS, Health Diagnostics
Seed
United States, Canada, Mexico

Portfolio highlights

Torch — Connect with us to put the power of trusted relationships to work. Invest in a culture of coaching, mentoring, and professional growth.
Unima — Unima is decentralizing rapid testing across industries by taking diagnostics out of the lab to the place these are needed the most to secure a timely diagnostic for everyone, anywhere.Unima is solving is the centralization of lab testing, which limits the access to a timely diagnostic for billions. Current technology for diagnostics is veryprecise and can detect almost any disease known, but the problem is these require labs with expensive equipment and specialized technicians making lab testing impossible to scale up to provide universal and timely access to diagnostics.To solve this problem Unima developed Find, a rapid testing technology platform for real time diagnostics which allows anyone to diagnose a disease directly where it is needed, without using lab equipment, with results in 15 minutes or less and at a very low cost. With Find anyone can have access to a timely diagnostic even in the most remote areas of the world.The Find platform uses shark antibodies modified with genetic engineering to detect disease biomarkers in blood, saliva, urine or water samples. These shark antibodies are used in microfluidic cards and generate a visual reactions when in contact with specific biomarkers of the disease to be tested. Then to evaluate the result of the test, a picture of the testing card is taken with the proprietary Xplora smartphone app which runs image analysis process and neural network algorithms to generate an inmediate result. Then this result,along with contextual information like geolocation, date and time, is sent to a cloud server where it can be used for real time disease tracking.
Enzyme — Enzyme QMS software includes modules for all stages of the product development life cycle from Design Control to CAPA. Our in-house experts are here to back you up! We can guide you through the quality challenges and regulatory submission process. Sign up for a Demo today.

Rob Stavis is a Partner at Bessemer Venture Partners.

Investment focus

Financial Services, FinTech, Finance
Series C, Series B, Series A
United States, Canada, Mexico

Portfolio highlights

Atarraya Inc — Explore Atarraya Farms commitment to sustainability and ethical seafood production. We create the most sustainable protein in the world through innovative aquaculture practices. Join us in revolutionizing the future of seafood
FLOWER CO — We sell weed on the internet. Thousands of products delivered overnight throughout California from Humboldt to San Diego
Bespoke Financial — Bespoke Financial is a licensed lender supporting cannabis companies. They alleviate working capital constraints across the entire cannabis supply chain. Bespoke supports their clients as they scale and grow with unique financing solutions and cannabis business loans.

Thomas James

Investment focus

Health Care, Biotechnology, Health Diagnostics
Seed
Mexico

Portfolio highlights

Unima — Unima is decentralizing rapid testing across industries by taking diagnostics out of the lab to the place these are needed the most to secure a timely diagnostic for everyone, anywhere.Unima is solving is the centralization of lab testing, which limits the access to a timely diagnostic for billions. Current technology for diagnostics is veryprecise and can detect almost any disease known, but the problem is these require labs with expensive equipment and specialized technicians making lab testing impossible to scale up to provide universal and timely access to diagnostics.To solve this problem Unima developed Find, a rapid testing technology platform for real time diagnostics which allows anyone to diagnose a disease directly where it is needed, without using lab equipment, with results in 15 minutes or less and at a very low cost. With Find anyone can have access to a timely diagnostic even in the most remote areas of the world.The Find platform uses shark antibodies modified with genetic engineering to detect disease biomarkers in blood, saliva, urine or water samples. These shark antibodies are used in microfluidic cards and generate a visual reactions when in contact with specific biomarkers of the disease to be tested. Then to evaluate the result of the test, a picture of the testing card is taken with the proprietary Xplora smartphone app which runs image analysis process and neural network algorithms to generate an inmediate result. Then this result,along with contextual information like geolocation, date and time, is sent to a cloud server where it can be used for real time disease tracking.
Miproto —

Sohail is the Founder & CEO of Destiny (D/XYZ).Sohail is also Founder & former Co-CEO of Forge, the stock market for private companies. He has an extensive background in product management, engineering, and business. As an eighteen-year-old, he was among the youngest founders to go through Y Combinator. Over the years, Sohail hasadvised and invested in over 100 startups, including notable startups such as Zenefits and Rappi. He continues to invest actively through S2 Capital, and serves as its Founding Partner. Prior to founding Equidate, Sohail managed mobile product at Zynga. He previously joined mobile advertising firm Chartboost as its second engineering hire, and has held roles at Google and the MIT Media Lab. Sohail was awarded TCU's Texas Youth Entrepreneur of the Year award in 2010, and was later named a Thiel Fellow by the Thiel Foundation. He previously attended Carnegie Mellon University where he studied Electrical & Computer Engineering.

Investment focus

Software, Financial Services, Information Technology
Seed, Series A
United States, France, Mexico

Portfolio highlights

Unima — Unima is decentralizing rapid testing across industries by taking diagnostics out of the lab to the place these are needed the most to secure a timely diagnostic for everyone, anywhere.Unima is solving is the centralization of lab testing, which limits the access to a timely diagnostic for billions. Current technology for diagnostics is veryprecise and can detect almost any disease known, but the problem is these require labs with expensive equipment and specialized technicians making lab testing impossible to scale up to provide universal and timely access to diagnostics.To solve this problem Unima developed Find, a rapid testing technology platform for real time diagnostics which allows anyone to diagnose a disease directly where it is needed, without using lab equipment, with results in 15 minutes or less and at a very low cost. With Find anyone can have access to a timely diagnostic even in the most remote areas of the world.The Find platform uses shark antibodies modified with genetic engineering to detect disease biomarkers in blood, saliva, urine or water samples. These shark antibodies are used in microfluidic cards and generate a visual reactions when in contact with specific biomarkers of the disease to be tested. Then to evaluate the result of the test, a picture of the testing card is taken with the proprietary Xplora smartphone app which runs image analysis process and neural network algorithms to generate an inmediate result. Then this result,along with contextual information like geolocation, date and time, is sent to a cloud server where it can be used for real time disease tracking.
Wethenew — Acquistate le vostre autentiche sneakers prodotti streetwear in edizione limitata in modo sicuro e protetto su wethenew.com!
Series — Series provides full-stack enterprise financial services designed for institutions & enterprises.

Jessica Livingston is a Co-founding partner. She is also the organizer of Startup School, the big annual startup conference, and the author of Founders at Work, a collection of interviews with successful startup founders.

Investment focus

Medical Device, Education, Health Care
Seed, Angel, Funding Round
United States, Mexico

Portfolio highlights

Balto — Balto, the sports gaming platform made for the casual, everyday fan. We’re thrilled to have you. As a quick intro, we’re Nick Montana, Spencer Cassidy and Joel Karacozoff, three individuals with a passion for gaming and an affinity for bringing people together. As driven co-founders to deliver the best experience, They have set out to create asimple, social and fun gaming interface for all.
Elpha — Elpha is where women succeed at work together. Become a member to access daily conversations with experts, insider job opportunities, and a lot of women talking candidly about work and life. Plus membership is free!
Hype and Vice — Hype and Vice combines on-trend fashion with University brands to create officially licensed college apparel women! Cool college apparel to wear for tailgates and gamedays or to lounge around your dorm.

Jason Burke is the Co-founder, Managing Director, and Investor of TBD Angels and the VP of Strategy and Business Development of Xandr. Prior to that, he was the Chief Strategy Officer for clypd, a Boston-based startup building an advertising technology platform exclusively for the TV industry and designed to empower media companies with actionablesales tools. In his role, Burke focuses on a forward-looking platform and business strategy, corporate development, partnerships, and management of clypd's strategic commercial deals.As one of the first employees at clypd, Burke spent over 3 years as VP, Product leading the product & operations teams in bringing innovative products to the $180B television advertising market. Prior to clypd, Burke spent six years building ad technology products for online video at ScanScout and Tremor Video where he had responsibility for product management, technical strategy and operations efforts.Jason is a leader with the unique experience of working with executive customer teams and internal product development/engineering groups to drive business while also solving software and implementation challenges with internal and external technical teams. He is also a frequent contributor to industry publications and participant on advertising technology and media conference presentations and panels. Jason holds several software patents focused on inventions in advertising technology and media.Jason is also an investor in early-stage companies across several verticals. He feels privileged to invest in and collaborate with talented founding teams seeking to change the world with innovative products & businesses.Jason is based in Boston and has degrees in Computer Science and Engineering Psychology from Tufts University.

Investment focus

Health Care, Information Technology, Internet
Seed, Pre-Seed, Angel
United States, Mexico

Portfolio highlights

Eva — Eva develops an accessible and non-invasive wearable device designed to detect breast cancer risks. The company's wearable device is equipped with tactile sensors which are designed to map the surface of the breast and surrounding areas, allowing women to keep a track on the changes in breast temperature, size, and weight, with the help ofbiosensors inside the cup which constantly monitors information.
Wrangle — Wrangle organizes requests in your Slack team channel. Automatically assign approvals and tasks for your team to follow up and track their status.
WorkAround — WorkAround is the accurate, scalable solution for adding human input to your data using an untapped workforce of domain experts.WorkAround's platform enables simple, quick annotation of data. Anything from classifying expenses into tax codes, annotating breast tissue to identify regions of interest, to identifying drug combinations fromclinical trial reports. We have the domain experts and a platform to facilitate a simple, secure processing of customer data and annotations.Companies that using WorkAround services not only save time and get quality service, but are also contributing to a more socially just and productive world where talent knows no boundaries, opportunity doesn’t ask for status, and work is rewarded with fair pay.

Movile's Founder & CEO, Fabricio Bloisi turned Movile from a startup in a garage in Brazil into a global player in mobile marketplaces. Currently, Movile has over 1600 employees, 15 offices – based in 6 different countries – and serves monthly more than 150 million mobile customers worldwide. Bloisi majored in Computer Science at theState University of Campinas (UNICAMP) and concluded a Master degree in Business Administration at Getulio Vargas Foundation (FGV/EAESP) – his thesis gathers High-Growth startups, Innovations and Strategy. Bloisi has also concluded the Executive Program for Growing Companies, Strategy, Finance, Leadership for companies in the growth phase at Stanford Graduate School of Business. His dream is to create a company that make's 1 billion lives better through Movile’s mobile businesses.

Investment focus

E-Commerce, Delivery, Internet
Series A, Angel, Series B
Brazil, Colombia, Argentina

Portfolio highlights

Moova — Moova is a technological platform that captures idle last mile logistic capacity and transforms it into high efficiency and low cost shipping solutions. The platform connects E-Commerce and retail businesses with a fleet of "Moovers" who complete deliveries on their bicycle, motorcycle, car or van to generate an additional source ofincome. Through route optimization software, real-time traceability, flexible warehousing, and analytics, Moova is propelling the nascent E-Commerce industry in Latin America by reimagining the last mile for a sustainable world.
BioLinker — BioLinker is a production of synthetic biology, protein synthesis kits, and protein.
Mercadoni — Mercadoni operates an online shopping platform that allows customers to purchase from stores and supermarkets from their homes. It sells groceries, alcoholic beverages, and more. Antonio Nunes, Pedro Freire, Margarita Freitas, Francesco Lanzi and Nicolas Fernández Talice founded Mercadoni in 2015. It has its headquarters in Bogota in Colombia.

Robert Goodman is a general partner at Goodman served as a director at he joined Bessemer Venture Partners. He has also worked at Goodman holds a bachelor’s degree in arts from

Investment focus

Software, SaaS, Information Technology
Series B, Series C, Series A
United States, Mexico, Germany

Portfolio highlights

Formally — Formally is a platform for legal collaboration. We leverage intelligent technology with behavioral science to create a whole new category of legal tech. And it all starts with immigration.
Tackle — Tackle helps you identify the right buyers, co-sell with your Cloud Partners, and transact through the Marketplaces with a platform built for Cloud GTM success.
Atarraya Inc — Explore Atarraya Farms commitment to sustainability and ethical seafood production. We create the most sustainable protein in the world through innovative aquaculture practices. Join us in revolutionizing the future of seafood

Mr. Kalish is a Partner at Aquiline Capital Partners. Previously, Mr. Kalish was also the Founder and Managing Director at Venturion Capital. He has served on the boards of numerous financial services companies in Europe and the US. He holds a history degree from Columbia and a masters degree in public policy from Harvard.

Investment focus

AgTech, Seafood, Biotechnology
Series A
Mexico

Portfolio highlights

Atarraya Inc — Explore Atarraya Farms commitment to sustainability and ethical seafood production. We create the most sustainable protein in the world through innovative aquaculture practices. Join us in revolutionizing the future of seafood

Dan Knox is one of the founders of Science Exchange, an online marketplace for science experiments. Prior to founding Science Exchange, Dan was Head of Operations at DailyMe, a pioneer in the field of dynamic personalization and predictive content and commerce presentation. Before joining DailyMe, Dan was Head of Economic Analysis within in theStrategy team at a leading commercial television network in the U.K., and a Senior Economist in the Media & Communications group of a global expert services consulting firm.Dan was part of the inaugural Executive MBA class at MIT Sloan School of Management. He also has a Master's degree and a Bachelor's degree in Economics, a Law degree and the Chartered Financial Analyst (CFA) qualification.

Investment focus

Finance, Health Care, Crowdfunding
Seed, Funding Round
Mexico, United States

Portfolio highlights

Unima — Unima is decentralizing rapid testing across industries by taking diagnostics out of the lab to the place these are needed the most to secure a timely diagnostic for everyone, anywhere.Unima is solving is the centralization of lab testing, which limits the access to a timely diagnostic for billions. Current technology for diagnostics is veryprecise and can detect almost any disease known, but the problem is these require labs with expensive equipment and specialized technicians making lab testing impossible to scale up to provide universal and timely access to diagnostics.To solve this problem Unima developed Find, a rapid testing technology platform for real time diagnostics which allows anyone to diagnose a disease directly where it is needed, without using lab equipment, with results in 15 minutes or less and at a very low cost. With Find anyone can have access to a timely diagnostic even in the most remote areas of the world.The Find platform uses shark antibodies modified with genetic engineering to detect disease biomarkers in blood, saliva, urine or water samples. These shark antibodies are used in microfluidic cards and generate a visual reactions when in contact with specific biomarkers of the disease to be tested. Then to evaluate the result of the test, a picture of the testing card is taken with the proprietary Xplora smartphone app which runs image analysis process and neural network algorithms to generate an inmediate result. Then this result,along with contextual information like geolocation, date and time, is sent to a cloud server where it can be used for real time disease tracking.
Experiment — Experiment is an online community and a crowdfunding platform for scientific research. It provides crowdfunding services for scientific research related to categories such as biology, chemistry, computer science, medicine, anthropology, psychology, engineering, and more.The platform provides its services for researchers from over 150institutions and universities around the world. It is in strategic partnerships with Experiment was founded by

Eric Urhane

Investment focus

Software, Health Care, Biotechnology
Seed, Angel
United States, Mexico, Singapore

Portfolio highlights

Unima — Unima is decentralizing rapid testing across industries by taking diagnostics out of the lab to the place these are needed the most to secure a timely diagnostic for everyone, anywhere.Unima is solving is the centralization of lab testing, which limits the access to a timely diagnostic for billions. Current technology for diagnostics is veryprecise and can detect almost any disease known, but the problem is these require labs with expensive equipment and specialized technicians making lab testing impossible to scale up to provide universal and timely access to diagnostics.To solve this problem Unima developed Find, a rapid testing technology platform for real time diagnostics which allows anyone to diagnose a disease directly where it is needed, without using lab equipment, with results in 15 minutes or less and at a very low cost. With Find anyone can have access to a timely diagnostic even in the most remote areas of the world.The Find platform uses shark antibodies modified with genetic engineering to detect disease biomarkers in blood, saliva, urine or water samples. These shark antibodies are used in microfluidic cards and generate a visual reactions when in contact with specific biomarkers of the disease to be tested. Then to evaluate the result of the test, a picture of the testing card is taken with the proprietary Xplora smartphone app which runs image analysis process and neural network algorithms to generate an inmediate result. Then this result,along with contextual information like geolocation, date and time, is sent to a cloud server where it can be used for real time disease tracking.
X-ZELL — Early, pain-free cancer cell detection
Chirply — Chirply is a platform for crowd-sourcing & crowd-curating design. Chirply's mission is to build engagement, stickiness, and virality through crowd-sourcing design. Initially the company focused on the launch of a marketplace for crowd-sourced design for paper goods - an industry that hasn't been disrupted since the advent of theprinting press. Chirply then launched a B2B platform for crowd-sourced design for brands to help engage users and use design to make daily products inspiring.

Mat Travizano is the Founder & Chairman at GranData.

Investment focus

PaaS, Bitcoin, FinTech
Seed, Series A
Spain, Argentina

Portfolio highlights

Michroma — Michroma is a biotech platform producing natural ingredients in a sustainable, scalable, and cost-effective way. We are using synthetic biology to unleash the potential of filamentous fungi and develop proprietary strains capable of producing high-performance ingredients in bioreactors.
Reloadly — Reloadly makes it easy for developers to connect with Mobile operator services. We are disrupting a Trillion dollar industry! Mobile Operators are stuck in old school business models, where most of the world is moving to open source platforms for developers to build amazing products. Reloadly is bridging the gap between mobile operators anddevelopers, and at the same time creating new sales channels for the 816 mobile operators around the world.
SenseiNode — We drive the decentralization of the blockchain ecosystem in Latin America with a simple, scalable and secure node management platform.

Paul Buchheit co-founded social network aggregator FriendFeed, along with three other former Google employees. He is also an investor in FriendFeed and participated in a $5 million Series A round in February 2008.He was the 23rd employee at Google, where he created Gmail and implemented many of its innovative features. He developed the originalprototype of Google AdSense, and was responsible for Google's famous "Don't be evil" motto in a meeting.

Investment focus

Software, Health Care, E-Commerce
Seed, Series A, Angel
United States, Canada, India

Portfolio highlights

SiPhox Health — SiPhox offers a handheld testing device with RNA/DNA and protein testing for point-of-care and At-Home solutions. The company's kit is made by multiplexing RNA, antibody, and antigen tests on a single silicon photonic chip which is amplified by plasmon resonance and silicon photonic resonator readout, enabling users to undertake tests fordisease safely and in a disposable point-of-care and at-home manner.SiPhox was founded in 2020 and is based in Cambridge, Massachusetts, USA.
Character.ai — Meet AIs that feel alive. Chat with anyone, anywhere, anytime. Experience the power of super-intelligent chat bots that hear you, understand you, and remember you.
Perplexity — Perplexity is a search engine platform that uses artificial intelligence to provide large language models and search engines. The company's platform enables the development of beneficial artificial general intelligence, as well as an open-source environment that is accessible to the public, allowing clients to develop skills and knowledge inartificial intelligence.

Jeff Horing has been a co-founder and managing director at Insight Venture Partners since 1995. Under his leadership Insight has become a premier venture capital and private equity firm focused on growth investments in software and internet businesses, currently investing from a $2.56 billion fund. Jeff's areas of focus include mobile,online gaming, data, infrastructure and internet software. Jeff is a former member of the board of directors of Airborne Entertainment (acquired by Cybird Co.), CTSpace (acquired by Sword Group), Beechwood Data Systems (acquired by Cap Gemini), Greenfield Online (IPO, later acquired by Microsoft), Hitwise (acquired by Experian Group Ltd), IAG Research (acquired by The Nielsen Company), ProMira Software (acquired by Manugistics), Shutterstock (IPO), SLP Infoware (acquired by Gemplus), Solarwinds Inc. (IPO NYSE: SWI), and Xchange (IPO acquired by Amdocs).Jeff is an investor or currently serves on the board of directors of AirWatch (mobile device management), Anaqua (IP asset management), GFI Software (cloud-based services), Jagex Ltd (online gaming), Nexon (online gaming), Datacore Software (storage virtualization), New Relic (application performance management), Teamviewer (remote desktop collaboration), WIX (free DIY flash-based websites), Whitney University System (distance learning technology), and Zumba (global fitness and lifestyle brand).Prior to founding Insight, Jeff was a key member of the technology investing team at Warburg Pincus. Earlier in his career he worked at Goldman Sachs in the Capital Markets group.Jeff holds an MBA from the M.I.T. Sloan School of Management. He has dual undergraduate degrees from the University of Pennsylvania’s Moore School of Engineering and Wharton School, where he graduated with high honors and was Phi Beta Kappa. Jeff is a regular speaker at Wharton as part of the Distinguished Guest speaker series.

Investment focus

Software, Artificial Intelligence, Information Technology
Series A, Series B, Series C
United States, Israel, Canada

Portfolio highlights

Atarraya Inc — Explore Atarraya Farms commitment to sustainability and ethical seafood production. We create the most sustainable protein in the world through innovative aquaculture practices. Join us in revolutionizing the future of seafood
Abnormal Security — Advanced email protection to prevent credential phishing, business email compromise, account takeover, and more.
Sensi.Ai — Sensi.Ai developed the first audio AI that's able to analyze the routine in long term care environments, detect anomalies and provide insight on trends, with the purpose of improving the quality of care

Doctor specialized in Diagnostic Imaging with more than 25 years of experience, also specialized in Breast Radiology, Occupational Health and Health Management, as well as in technological developments

Investment focus

Medical, Wellness, Health Care
Pre-Seed
Peru

Portfolio highlights

Veo365 — Veo365 is a mobile/desktop solution for medical monitoring, occupational health, epidemiological surveillance, health education/prevention and real-time operational standards for companies, organizations, and in general for communities and governments. Their digital solution also integrates wearables and machine learning for a betterhealth diagnostic experience.Veo365 is headquartered in Lima, Peru and was founded in 2019.

Ashton Kutcher is an actor, investor, entrepreneur, producer and philanthropist.Kutcher has been named one of TIME magazine’s “100 Most Influential People in the World,” as well as being honored by Vanity Fair ‘s “New Establishment List,” which identifies the top 50 of an innovative new breed of buccaneering visionaries, engineering prodigiesand entrepreneurs. Twice, Kutcher was named one of Forbes magazine’s “World’s Most Powerful Celebrities,” as well as one of Fast Company magazine’s “Most Creative People.”Kutcher has been investing in technology for over a decade, both as an angel investor and a founding partner of A-Grade Investments and Sound Ventures. His fund portfolio includes Airbnb, Uber, Flexport, Brex, Robinhood, Bird, Airtable and Affirm among others.Kutcher is also the co-founder of Thorn: Digital Defenders of Children (www.thorn.org). Thorn drives technology innovation to fight the sexual exploitation of children.Kutcher currently stars in the Netflix original series, The Ranch. He also serves as Executive Producer. Until 2015, Kutcher starred in the CBS comedy series Two and a Half Men. The show ranked as the second most-watched comedy on all of network television. Kutcher first gained recognition as Michael Kelso on the Fox series That 70’s Show, and went on to star in a variety of box office hits on the big screen – including What Happens In Vegas with Cameron Diaz, The Guardian with Kevin Costner, No Strings Attached with Natalie Portman and the cult hit Dude, Where’s My Car.Kutcher served as co-creator and producer of MTV's hit series, “Punk'd,” and The CW's reality series “Beauty and the Geek” and “True Beauty.” He has also produced films such as No Strings Attached, Killers and The Butterfly Effect. Additionally, Kutcher co-founded APlus, a digital media company devoted to spreading the message of positive journalism, a kind of storytelling that focuses on our shared humanity. In 2016, APlus was purchased by Chicken Soup for the Soul.

Investment focus

Software, E-Commerce, Apps
Seed, Series A, Series B
United States, Germany, Canada

Portfolio highlights

QD-SOL — QD-SOL uses nanoparticles to produce green hydrogen in half the time.
Spicewell — Spicewell develops and creates food seasoning products that includes various kinds of micronutrients. It uses modern science to infuse healthy and organic additions to food meals. Spicewell is based in California, USA.
HempNFibers — Growing hemp. Making a bio fuel to start. Than also an insulation out of it as well. Will look at doing more as company grows. I also know a way to power a whole warehouse by just the plants it’s self but I need funding to get this started. I’m building the transportation side just so I can gain an income to try and get this started.

Armínio Fraga

Investment focus

Recruiting, SaaS, EdTech
Seed, Pre-Seed, Series A
Brazil

Portfolio highlights

gen-t — Gen-t is a platform capable of providing the map of genomic research. Gen-t was founded in 2021 and was headquartered in Sao Paulo, Brazil.
Jobecam — Jobecam is a SaaS which uses video technology to help recruiters to reduce unconcious biases during hiring process applying AI, concealing the candidates' identity, by blurring their images and changing their voices in the video interviews or video resume. With this, we help the decision-maker to evaluate candidates just for their competences,abilities and experiences instead of their gender, race, ethinic, religion, etc.Our IA do a match between the recruiter's requirements and the audio transcriptions from the video interviews to ranking the best profiles. In this point we already are by designed to reduce biases besides optimizing the hiring process, reducing unnecessary interviews.We are supported by Oracle, Estação Hack Facebook, Artemísia, IBMEC, People Strategy, BR and Harvard Angels BrazilThinking at efficiency and diversity during hiring process we are promoting a world to value difference in companies!Learn more at www.jobecam.com
Galena — Established in 2020, Galena trains and develops young talented individuals for the jobs of the future.

Matt Cutts joined Google as a Software Engineer in January 2000. Before Google, he was working on his Ph.D. in computer graphics at the University of North Carolina at Chapel Hill. He has an M.S. from UNC-Chapel Hill, and B.S. degrees in both mathematics and computer science from the University of Kentucky.Matt wrote SafeSearch, which isGoogle's family filter. In addition to his experience at Google, Matt held a top-secret clearance while working for the Department of Defense, and he's also worked at a game engine company. He claims that Google is the most fun by far.Matt talks about webmaster-related issues on his

Investment focus

SaaS, Health Care, Software
Seed, Angel, Series A
United States, Canada, Mexico

Portfolio highlights

Unima — Unima is decentralizing rapid testing across industries by taking diagnostics out of the lab to the place these are needed the most to secure a timely diagnostic for everyone, anywhere.Unima is solving is the centralization of lab testing, which limits the access to a timely diagnostic for billions. Current technology for diagnostics is veryprecise and can detect almost any disease known, but the problem is these require labs with expensive equipment and specialized technicians making lab testing impossible to scale up to provide universal and timely access to diagnostics.To solve this problem Unima developed Find, a rapid testing technology platform for real time diagnostics which allows anyone to diagnose a disease directly where it is needed, without using lab equipment, with results in 15 minutes or less and at a very low cost. With Find anyone can have access to a timely diagnostic even in the most remote areas of the world.The Find platform uses shark antibodies modified with genetic engineering to detect disease biomarkers in blood, saliva, urine or water samples. These shark antibodies are used in microfluidic cards and generate a visual reactions when in contact with specific biomarkers of the disease to be tested. Then to evaluate the result of the test, a picture of the testing card is taken with the proprietary Xplora smartphone app which runs image analysis process and neural network algorithms to generate an inmediate result. Then this result,along with contextual information like geolocation, date and time, is sent to a cloud server where it can be used for real time disease tracking.
X-ZELL — Early, pain-free cancer cell detection
Meter Feeder — Easily pay for parking through MeterFeeder

Jun Ueki is the CEO at Keiretsu Forum Japan.

Investment focus

Biopharma, Biotechnology, Food Processing
Seed, Funding Round
Argentina

Portfolio highlights

CarLabs —
Michroma — Michroma is a biotech platform producing natural ingredients in a sustainable, scalable, and cost-effective way. We are using synthetic biology to unleash the potential of filamentous fungi and develop proprietary strains capable of producing high-performance ingredients in bioreactors.

Wolfgang Schuch

Investment focus

Farming, Chemical, Agriculture
Seed
Chile

Portfolio highlights

Botanical Solutions — BSI produces plant-based biofungicides for sustainable agriculture & advanced botanical materials for the gold standard vaccine adjuvant QS-21

Eduardo Mufarej built his career in private equity and education as an investor and entrepreneur. He co-founded and was CEO of Tarpon Investimentos, one of Brazil’s largest independent investment managers. He served on several boards and was Chairman of Somos Educação and Omega Energia Renovável. From 2014 until 2018 Eduardo led the largest k-12company in Latin America, Abril Educação, which he managed until the sale of the company to Kroton Educacional in October 2018. After the sale, Eduardo created Renova, a project focused on selecting and training a new generation of leaders in Brazilian politics. Since its creation, the program has supported and trained over 2000 individuals in Brazil, helping to elect 176 of its students. This effort awarded Eduardo the prize Brazilian Entrepreneur of the Year in 2018. In early 2020, Eduardo co-founded Galena, a company that supports and trains individuals for their first jobs. Eduardo is a member of the advisory board of the Wilson Institute, in Washington, DC, of the Yale University SOM Council of Global Advisors and a fellow at Stanford’s Graduate School of Education. He is the author of the book Jornada Improvável (Unlikely Journey, 2021).

Investment focus

EdTech, Genetics, Education
Seed, Pre-Seed
Brazil, Colombia

Portfolio highlights

gen-t — Gen-t is a platform capable of providing the map of genomic research. Gen-t was founded in 2021 and was headquartered in Sao Paulo, Brazil.
HUNTY — HUNTY is a platform that help people find jobs by connecting them with world class mentors who prepare them for the job search process. And people only pay when they get hired.
Alicerce — Alicerce is a social impact platform designed to support middle-class education. It offers an educational solution, focused on what is most important and promotes the social ascension of Brazilian families.The company is driven by a mission to provide a successful opportunity for all young Brazilians through quality education.Alicerce wasfounded in 2017 and is headquartered in Sao Paulo, Brazil.

Investors by industry